A senior Mexican official said yesterday that Mexico will receive about 4 million doses of AstraZeneca’s coronavirus vaccine by the end of next week. These shipments may help Latin America respond more quickly to the pandemic.
According to the official quoted by Reuters, about 1.3 million doses of this vaccine arrived in Mexico from the United States on Thursday night.
Official and other government sources added that the vaccine originated in Argentina, where the active ingredient was produced, and that the material was shipped to the United States for supplementation before reaching Mexico.
Argentina and Mexico jointly produce vaccines for the region, which has one of the most severe infection rates in the world.
Countries in Latin America are struggling to find enough vaccine stocks to combat this infection.
Due to problems in preparing vaccines at the Mexican bottling plant, the project in the region was delayed for several months, and Argentina instead sent some active ingredients to the United States for processing.
The first dose under this regional agreement should be used as early as next week.
Mexico also requested that millions of doses of AstraZeneca vaccine be purchased from US stocks, but it has not yet been approved for use in the country.
The Mexican government previously pointed out that since Thursday, the shipment has contained 1.2 million doses. The official said that the remaining 2.7 million doses will arrive in Mexico between this week and next week.
The representative of the Argentine government said that at the moment I cannot be sure that the Argentine vaccine produced in Mexico will arrive next week.
After the initial problems caused by the delayed delivery of the promised vaccine, Mexico’s efforts to vaccinate the population have accelerated in recent weeks.
According to data from the Ministry of Health, Mexico vaccinated a record 727,638 people on Wednesday.